These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17194546

  • 1. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
    Tugnoli V, Capone JG, Eleopra R, Quatrale R, Sensi M, Gastaldo E, Tola MR, Geppetti P.
    Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P, Pedersen NS, Staahl C, Drewes AM, Arendt-Nielsen L.
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
    Schulte-Mattler WJ, Opatz O, Blersch W, May A, Bigalke H, Wohlfahrt K.
    J Neurol Sci; 2007 Sep 15; 260(1-2):38-42. PubMed ID: 17481662
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
    Diener SA, Breimhorst M, Vogt T, Krämer HH, Drummond PD, Geber C, Birklein F.
    Eur J Pain; 2017 Sep 15; 21(8):1326-1335. PubMed ID: 28440002
    [Abstract] [Full Text] [Related]

  • 6. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
    Krämer HH, Angerer C, Erbguth F, Schmelz M, Birklein F.
    J Neurol; 2003 Feb 15; 250(2):188-93. PubMed ID: 12574949
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D, Attal N, Morain F, Bouhassira D.
    Ann Neurol; 2008 Sep 15; 64(3):274-83. PubMed ID: 18546285
    [Abstract] [Full Text] [Related]

  • 8. A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model.
    Sycha T, Samal D, Chizh B, Lehr S, Gustorff B, Schnider P, Auff E.
    Anesth Analg; 2006 Feb 15; 102(2):509-16. PubMed ID: 16428552
    [Abstract] [Full Text] [Related]

  • 9. Experimental forearm immobilization in humans reduces capsaicin-induced pain and flare.
    Terkelsen AJ, Bach FW, Jensen TS.
    Brain Res; 2009 Mar 31; 1263():43-9. PubMed ID: 19368813
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of somatic small fiber neuropathy in obesity.
    Herman RM, Brower JB, Stoddard DG, Casano AR, Targovnik JH, Herman JH, Tearse P.
    Int J Obes (Lond); 2007 Feb 31; 31(2):226-35. PubMed ID: 16770330
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M, Silva S, Cottrell C.
    Headache; 2008 Feb 31; 48(10):1476-81. PubMed ID: 19076646
    [Abstract] [Full Text] [Related]

  • 12. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A.
    Chuang YC, Yoshimura N, Wu M, Huang CC, Chiang PH, Tyagi P, Chancellor MB.
    Eur Urol; 2007 Apr 31; 51(4):1119-27. PubMed ID: 17141941
    [Abstract] [Full Text] [Related]

  • 13. Loss of capsaicin-induced meningeal neurogenic sensory vasodilatation in diabetic rats.
    Dux M, Rosta J, Pintér S, Sántha P, Jancsó G.
    Neuroscience; 2007 Nov 30; 150(1):194-201. PubMed ID: 17920775
    [Abstract] [Full Text] [Related]

  • 14. Differential time courses of skin blood flow and hyperalgesia in the human sunburn reaction following ultraviolet irradiation of the skin.
    Benrath J, Gillardon F, Zimmermann M.
    Eur J Pain; 2001 Nov 30; 5(2):155-67. PubMed ID: 11465981
    [Abstract] [Full Text] [Related]

  • 15. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD.
    Neurology; 2005 Oct 25; 65(8):1306-8. PubMed ID: 16247065
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series.
    Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N.
    Pain Pract; 2007 Dec 25; 7(4):337-40. PubMed ID: 17986166
    [Abstract] [Full Text] [Related]

  • 17. Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.
    Westerman RA, Roberts RG, Kotzmann RR, Westerman DA, Delaney C, Widdop RE, Carter BE.
    Clin Exp Neurol; 1988 Dec 25; 25():71-84. PubMed ID: 3267488
    [Abstract] [Full Text] [Related]

  • 18. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May 25; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B.
    Pain Med; 2009 Sep 25; 10(6):1012-7. PubMed ID: 19594841
    [Abstract] [Full Text] [Related]

  • 20. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
    Gazerani P, Staahl C, Drewes AM, Arendt-Nielsen L.
    Pain; 2006 Jun 25; 122(3):315-325. PubMed ID: 16677761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.